Profile
ARTV VRTX REGN VRNA ARGX ALNY
Company Name Artiva Biotherapeutics, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $94.99M $122.53B $81.62B $72.68B $50.22B $43.35B
Employees 0.10K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO Fred Aslan Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
ARTV VRTX REGN VRNA ARGX ALNY
Quant Rating Score 2 4 4 1 4 3
Quant Rating Sell Buy Buy Strong Sell Buy Neutral
Trading
ARTV VRTX REGN VRNA ARGX ALNY
Last Close $3.51 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $12.78 $513.76 $788 $106.91 $929.61 $491.09
Low 52 $1.47 $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High -72.54 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low 138.78 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
ARTV VRTX REGN VRNA ARGX ALNY
1 Month Return -41.6 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return 13.23 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return 72.91 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return -14.39 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return -65.18 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return -68.94 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ARTV VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.45 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -34.38 % 9.76 % 3.92 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 8.22 % - - -
Growth
ARTV VRTX REGN VRNA ARGX ALNY
Asset Growth 99.38 % 7.41 % 53.91 % 10.71 %
Gross Profit Growth -99.25 % 1.16 % - 26.81 %
Revenue Growth -99.25 % 0.99 % - 22.97 %
Revenue 3 Year -90.95 % 20.64 % -15.89 % 147.1 %
Revenue 5 Year - 73.64 % - 775.72 %
Revenue 10 Year - 285.02 % - 2487.4 %
EBIT Growth -119.37 % 9.09 % -131.37 % 24.59 %
Net Income Growth -111.2 % 2.09 % -224.78 % 36.82 %
Net Income 3 Yeari Growth Per Share 41.22 % 6.32 % -148.34 % 69.73 %
Net Income 5 Yeari Growth Per Share - 31.91 % 25.82 % 73.13 %
Net Income 10 Yeari Growth Per Share - 680.22 % -35.51 % 55.09 %
Operating Income Growth -119.37 % -7.46 % -133.02 % 37.31 %
Operating Cash Flow Growth (CFG) -16.03 % - -143.33 % -107.98 %
Operating 3 Year CFG -159.52 % -100 % -170.73 % 98.8 %
Operating 5 Year CFG - -100 % 54.81 % 97.44 %
Operating 10 Year CFG - -100 % 40.15 % 97.08 %
EPS Growth -336.97 % 5.31 % -214.81 % 38.07 %
EPS Diluted Growth -336.97 % 8.19 % -208.93 % 38.07 %
Book Value Per Share 210.09 % 32.88 % -22.82 % 129.75 %
Share Holder 3 Year Equity Growth Per Share 251.59 % 41.21 % 1.82 % -89.42 %
Share Holder 5 Year Equity Growth Per Share - 191.63 % -24.45 % -96.01 %
Share Holder 10 Year Equity Growth Per Share - 842.11 % -71.86 % -95.83 %
Dividend Per Share Growth - - - -
Dividend 3 Year Growth Per Share - - - -
Dividend 5 Year Growth Per Share - - - -
Dividend 10 Year Growth Per Share - - - -
Debt Growth -15.13 % 0.06 % 139.05 % 110.16 %
Free Cash Flow Growth -9.84 % - -144.48 % -201.54 %
Updated On 31 Dec 2024 31 Dec 2025 31 Dec 2024 31 Dec 2024
Profitability
ARTV VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM - 86.28 % 86.27 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM -48.57 % 14.78 % 11.11 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM -45.64 % 21.81 % 14.83 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM -62.54 % 19.59 % 10.3 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 100 % 82.61 % 86.12 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM 83.94 % 111.4 % 146.19 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM - 34.06 % 24.95 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM -655.85 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM - 6.02 2.5 1.93 1.91 3.33
Payables Turnover TTM 0.78 0.4 2.1 2.37 0.9 4.37
Inventory Turnover TTM - 0.99 0.62 0.94 2.26 6.82
Fixed Asset Turnover TTM - 388.59 % 280.11 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM - 47.15 % 35.36 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM -3.13 14.55 48.39 -0.85 5.67 2.02
Free Cash Flow Per Share TTM -3.22 13.06 39.66 -0.85 5.58 1.68
Cash Per Share TTM 502.28 % 2459.7 % 8362.68 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM - 31.71 % 34.71 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 102.91 % 89.76 % 81.96 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM -655.85 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM -1.2 36.72 20 -995.27 127.92 195.85
Price To Operating Cash Flows Ratio TTM -1.24 32.86 16.23 -126.33 144.41 162.25
Price Cash Flow Ratio TTM -1.24 32.86 16.23 -126.33 144.41 162.25
Income Statement (TTM)
ARTV VRTX REGN VRNA ARGX ALNY
Revenue $0B $11.02B $14.34B $0.03B $2.19B $2.25B
Gross Profit $0B $9.49B $12.24B $0.03B $1.96B $1.92B
Gross Profit Ratio 100% 86.11% 85.35% 93.89% 89.62% 85.62%
EBITDA $-0.06B $0.49B $5.82B $-0.12B $0.11B $-0.18B
Net Income $-0.06B $-0.54B $4.5B $-0.14B $0.83B $-0.28B
EPS Diluted -5.2 -2.08 41.48 -1.73 12.78 -2.18
Balance Sheet (MRQ)
ARTV VRTX REGN VRNA ARGX ALNY
Long Term Debt $0.01B $1.66B $2.71B $0.12B $0.03B $2.59B
Total Liabilities $0.02B $6.12B $9.3B $0.27B $0.7B $4.17B
Total Equity $0.19B $16.41B $31.26B $0.2B $5.5B $0.07B
Total Investments $0.15B $6.65B $15.75B $0.02B $1.93B $1.73B
Total Debt $0.01B $1.75B $2.71B $0.12B $0.04B $2.74B
Total Assets $0.21B $22.53B $40.56B $0.47B $6.2B $4.24B
Cash Flow Statement (TTM)
ARTV VRTX REGN VRNA ARGX ALNY
Net Income $-0.07B $-0.54B $4.5B $-0.17B $0.83B $-0.28B
Inventory $0B $-0.52B $-0.28B $-0.01B $-0.1B $0.01B
Dividends Paid $0B $0B $-0.37B $0B $0B $0B
Operating Cash Flow $-0.06B $-0.49B $4.98B $-0.12B $-0.08B $-0.01B
Capital Expenditure $-0B $-0.3B $-0.9B $-0B $-0.07B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 24
AARD Aardvark Therapeutics, Inc. Common Stock 12.3411
ABCL AbCellera Biologics Inc. 3.0687
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.04
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.45
ABPWW 0.0133
ABSI Absci Corporation 2.505
ABUS Arbutus Biopharma Corporation 4.01
ABVC ABVC BioPharma, Inc. 1.65
ABVX Abivax SA American Depositary Shares 123.45
ACAD ACADIA Pharmaceuticals Inc. 22.242
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 6.876
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.21
ACIU AC Immune SA 2.97
ETFs With Exposure to ARTV
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.0001 264.91
VTI Vanguard Total Stock Market Index Fund 0.00003 341.79
IBB iShares Biotechnology ETF 0 171.471
IWN iShares Russell 2000 Value ETF 0.00011 200.6
IWO iShares Russell 2000 Growth ETF 0.00013 338.45
BIB ProShares Ultra Nasdaq Biotechnology 0.00611831 83.12
VXF Vanguard Extended Market Index Fund 0.0003 218.35
HDG ProShares Hedge Replication ETF 0.000167861 52.93
UWM ProShares Ultra Russell2000 0.000980364 53.81
VTHR Vanguard Russell 3000 Index Fund 0 306.12
IWC iShares Micro-Cap ETF 0 166.94
URTY ProShares UltraPro Russell2000 0.000784157 64.7
VTWV Vanguard Russell 2000 Value Index Fund 0.00152 176.985
VTWG Vanguard Russell 2000 Growth Index Fund 0.0017 247.8
VTWO Vanguard Russell 2000 Index Fund 0.00151 107.09
XSU.TO iShares U.S. Small Cap Index ETF (CAD-Hedged) 0 50.1
VUN.TO Vanguard U.S. Total Market Index ETF 0.00003 126.18
VUS.TO Vanguard U.S. Total Market Index ETF (CAD-hedged) 0.00003 118.65
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0.00007 115
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 114.98
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 52.53
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 52.52
VBINX Vanguard Balanced Index Fund Investor Shares 0 52.53
VGRO.TO Vanguard Growth ETF Portfolio 0.00001 44.4
VEQT.TO Vanguard All-Equity ETF Portfolio 0.00001 55.87
VBAL.TO Vanguard Balanced ETF Portfolio 0.00001 37.88
VCNS.TO Vanguard Conservative ETF Portfolio 0.00001 32.16
VCIP.TO Vanguard Conservative Income ETF Portfolio 0 27.38
VRIF.TO Vanguard Retirement Income ETF Portfolio 0 27.03
IBBQ Invesco Nasdaq Biotechnology ETF 0.009618 29.1501
DFAS Dimensional U.S. Small Cap ETF 0.00001934 76.35
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0 7.252
VTSAX Vanguard Total Stock Market Index Fund 0.00003 166.24
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0 8.661
SBIO.MI Invesco NASDAQ Biotech UCITS ETF 0.0094 51.76
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.0003 165.55
VITSX Vanguard Total Stock Market Index Fund 0.00003 166.27
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF 0 8.589
SBIO.L Invesco NASDAQ Biotech UCITS ETF 0.0094 61.74
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.0003 165.56
BTEK.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0 6.29
VTS.AX Vanguard US Total Market Shares Index ETF 0.00003 484.72
DCOR Dimensional ETF Trust 0.00044104 76.67
VEMPX Vanguard Extended Market Index InstlPlus 0.0003 408.54
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00003 311.9
RSSL Global X Funds 0 103.705
Unlock